Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

被引:0
作者
Bernd Lange
Brigitte Kuperwasser
Akiko Okamoto
Achim Steup
Thomas Häufel
Judy Ashworth
Mila Etropolski
机构
[1] Global Development,
[2] Grünenthal GmbH,undefined
[3] Johnson & Johnson Pharmaceutical Research & Development,undefined
来源
Advances in Therapy | 2010年 / 27卷
关键词
chronic pain; EQ-5D; low back pain; opioid responder rates; opioid tolerability; osteoarthritis; oxycodone controlled release; quality of life; tapentadol prolonged release; SF-36; treatment discontinuation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:381 / 399
页数:18
相关论文
共 63 条
[31]  
Trescot A.M.(undefined)undefined undefined undefined undefined-undefined
[32]  
Datta S.(undefined)undefined undefined undefined undefined-undefined
[33]  
Bell T.J.(undefined)undefined undefined undefined undefined-undefined
[34]  
Panchal S.J.(undefined)undefined undefined undefined undefined-undefined
[35]  
Miaskowski C.(undefined)undefined undefined undefined undefined-undefined
[36]  
Bolge S.C.(undefined)undefined undefined undefined undefined-undefined
[37]  
Milanova T.(undefined)undefined undefined undefined undefined-undefined
[38]  
Williamson R.(undefined)undefined undefined undefined undefined-undefined
[39]  
Tzschentke T.M.(undefined)undefined undefined undefined undefined-undefined
[40]  
Christoph T.(undefined)undefined undefined undefined undefined-undefined